Yajing Mi

1.4k total citations
31 papers, 1.1k citations indexed

About

Yajing Mi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Yajing Mi has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Neurology. Recurrent topics in Yajing Mi's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Nerve injury and regeneration (5 papers) and Signaling Pathways in Disease (5 papers). Yajing Mi is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Nerve injury and regeneration (5 papers) and Signaling Pathways in Disease (5 papers). Yajing Mi collaborates with scholars based in China, United States and Hong Kong. Yajing Mi's co-authors include Xingchun Gao, Xingchun Gou, Weilin Jin, Na Guo, Lixian Xu, Zhifang Hu, Xiaojuan Han, Tianying Zhang, Yuelin Zhang and Huanhuan Liu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Yajing Mi

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yajing Mi China 17 495 213 202 190 183 31 1.1k
Marta Segarra Germany 19 495 1.0× 165 0.8× 98 0.5× 117 0.6× 134 0.7× 24 1.1k
Belinda Cairns United States 12 494 1.0× 189 0.9× 111 0.5× 68 0.4× 93 0.5× 15 1.1k
Inga Schmidt Germany 9 880 1.8× 251 1.2× 153 0.8× 98 0.5× 116 0.6× 10 1.6k
Bàrbara Laviña Sweden 15 852 1.7× 183 0.9× 119 0.6× 136 0.7× 282 1.5× 23 2.1k
Lynn C. Shaw United States 27 938 1.9× 137 0.6× 199 1.0× 112 0.6× 149 0.8× 42 1.8k
Qinbo Zhou United States 20 871 1.8× 135 0.6× 509 2.5× 127 0.7× 95 0.5× 26 1.4k
Francisco Sánchez‐Sánchez Spain 22 842 1.7× 87 0.4× 169 0.8× 98 0.5× 236 1.3× 55 1.6k
Zhongshu Tang China 20 593 1.2× 103 0.5× 116 0.6× 46 0.2× 118 0.6× 35 1.1k
Lars Tatenhorst Germany 20 664 1.3× 94 0.4× 161 0.8× 73 0.4× 95 0.5× 31 1.5k
David L. Schonberg United States 10 385 0.8× 74 0.3× 196 1.0× 132 0.7× 128 0.7× 13 828

Countries citing papers authored by Yajing Mi

Since Specialization
Citations

This map shows the geographic impact of Yajing Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Mi more than expected).

Fields of papers citing papers by Yajing Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajing Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Mi. The network helps show where Yajing Mi may publish in the future.

Co-authorship network of co-authors of Yajing Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Yajing Mi. A scholar is included among the top collaborators of Yajing Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajing Mi. Yajing Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mi, Yajing, et al.. (2025). Peptide‑based therapeutic strategies for glioma: Current state and prospects. Peptides. 185. 171354–171354. 1 indexed citations
2.
Nian, Shen, Acy Lo, Yajing Mi, Kai Ren, & Di Yang. (2021). Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye and Vision. 8(1). 15–15. 95 indexed citations
3.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2020). The mechanism of propofol in cancer development: An updated review. Asia-Pacific Journal of Clinical Oncology. 16(2). e3–e11. 32 indexed citations
4.
Han, Xiaojuan, Tianying Zhang, Huanhuan Liu, Yajing Mi, & Xingchun Gou. (2020). Astrocyte Senescence and Alzheimer’s Disease: A Review. Frontiers in Aging Neuroscience. 12. 148–148. 118 indexed citations
5.
Li, Haorong, Wenmin Cheng, Honghui Li, et al.. (2020). High-Quality Genome Assembly of Chrysaora quinquecirrha Provides Insights Into the Adaptive Evolution of Jellyfish. Frontiers in Genetics. 11. 535–535. 10 indexed citations
6.
Hu, Zhifang, et al.. (2020). A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis. Frontiers in Oncology. 10. 897–897. 80 indexed citations
7.
Han, Xiaojuan, Tianying Zhang, Xiaohua Zhang, et al.. (2020). AMPK alleviates oxidative stress‑induced premature senescence via inhibition of NF-κB/STAT3 axis-mediated positive feedback loop. Mechanisms of Ageing and Development. 191. 111347–111347. 20 indexed citations
8.
Mi, Yajing, Na Guo, Jing Luan, et al.. (2020). The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment. Frontiers in Immunology. 11. 737–737. 106 indexed citations
9.
Mi, Yajing, Xingchun Gao, Hao Xu, et al.. (2019). The Emerging Roles of Ferroptosis in Huntington’s Disease. NeuroMolecular Medicine. 21(2). 110–119. 89 indexed citations
10.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2018). Glioma in Schizophrenia: Is the Risk Higher or Lower?. Frontiers in Cellular Neuroscience. 12. 289–289. 19 indexed citations
11.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2017). Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy. Frontiers in Immunology. 8. 774–774. 122 indexed citations
12.
Deng, Bin, Hao Xu, Junfeng Zhang, et al.. (2016). PirB Overexpression Exacerbates Neuronal Apoptosis by Inhibiting TrkB and mTOR Phosphorylation After Oxygen and Glucose Deprivation Injury. Cellular and Molecular Neurobiology. 37(4). 707–715. 13 indexed citations
13.
Mi, Yajing, et al.. (2014). PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals. Journal of drug targeting. 22(5). 365–371. 23 indexed citations
14.
Mi, Yajing, Xingchun Gao, Yue Ma, et al.. (2014). A novel centrosome and microtubules associated subcellular localization of Nogo-A: Implications for neuronal development. The International Journal of Biochemistry & Cell Biology. 57. 1–6. 6 indexed citations
15.
Ma, Yue, Keng Chen, Yajing Mi, et al.. (2014). A link between the nuclear-localized srGAP3 and the SWI/SNF chromatin remodeler Brg1. Molecular and Cellular Neuroscience. 60. 10–25. 8 indexed citations
16.
Guo, Fan, Weilin Jin, Liya Li, et al.. (2013). M9, A Novel Region of Amino‐Nogo‐A, Attenuates Cerebral Ischemic Injury by Inhibiting NADPH Oxidase‐Derived Superoxide Production in Mice. CNS Neuroscience & Therapeutics. 19(5). 319–328. 11 indexed citations
17.
18.
Zhao, Yuwu, Fang Liu, Yajing Mi, et al.. (2013). Rapidly Raise Blood Sugar Will Aggravate Brain Damage After Severe Hypoglycemia in Rats. Cell Biochemistry and Biophysics. 69(1). 131–139. 6 indexed citations
19.
Chen, Keng, Yajing Mi, Yueyun Ma, Hualin Fu, & Weilin Jin. (2011). The Mental Retardation Associated Protein, srGAP3 Negatively Regulates VPA-Induced Neuronal Differentiation of Neuro2A Cells. Cellular and Molecular Neurobiology. 31(5). 675–686. 15 indexed citations
20.
Shao, Zhicheng, Qian Luo, Dandan Liu, et al.. (2010). Induced Differentiation of Neural Stem Cells of Astrocytic Origin to Motor Neurons in the Rat. Stem Cells and Development. 20(7). 1163–1170. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Segarra Breakdown of academic impact, for papers by Belinda Cairns Breakdown of academic impact, for papers by Inga Schmidt Breakdown of academic impact, for papers by Bàrbara Laviña Breakdown of academic impact, for papers by Lynn C. Shaw Breakdown of academic impact, for papers by Qinbo Zhou Breakdown of academic impact, for papers by Francisco Sánchez‐Sánchez Breakdown of academic impact, for papers by Zhongshu Tang Breakdown of academic impact, for papers by Lars Tatenhorst Breakdown of academic impact, for papers by David L. Schonberg
Rankless by CCL
2026